Twelve members of Vanderbilt's faculty have been elected fellows of the American Association for the Advancement of Science for their “scientifically or socially distinguished efforts to advance science or its applications.”

Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk.

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

The Tennessee Public Health Association and the Tennessee Medical Association are collaborating to establish the “William Schaffner, M.D., Public Health Hero Award,” to be presented annually to an individual who has demonstrated extraordinary efforts in the advancement of public health in Tennessee.

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.

William Schaffner, M.D., professor of Preventive Medicine at Vanderbilt University Medical Center, received the Immunization Champion Award — Friend of Pharmacy from the American Pharmacists Association (APA) at the group’s annual meeting recently in Orlando, Fla.